(Q40034606)

16 September 2017

The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas (English)

1 reference

16 September 2017

Claudiu V Cotta

1

1 reference

16 September 2017

Vasiliki Leventaki

2

1 reference

16 September 2017

Vassilis Atsaves

3

1 reference

16 September 2017

Athina Vidaki

4

1 reference

16 September 2017

Ellen Schlette

5

1 reference

16 September 2017

Dan Jones

6

1 reference

16 September 2017

L Jeffrey Medeiros

7

1 reference

16 September 2017

George Z Rassidakis

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

112

1 reference

16 September 2017

3

1 reference

16 September 2017

552-561

1 reference

Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins

16 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

E protein function in lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id family of helix-loop-helix proteins in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Transcriptional profiling identifies Id2 function in dendritic cell development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

BMP4 regulates pancreatic progenitor cell expansion through Id2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

The balance between Pax5 and Id2 activities is the key to AID gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Transcriptional regulator Id2 mediates CD8+ T cell immunity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Expression of Id2 mRNA in neuroblastoma and normal ganglion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id2 is dispensable for myc-induced lymphomagenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Prognostic value of MYCN and ID2 overexpression in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Impairment of intestinal intraepithelial lymphocytes in Id2 deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23196

7 January 2021

Identifiers

DOI

10.1002/CNCR.23196

1 reference

16 September 2017

1 reference